IMVT
Immunovant, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -12.5% ·
aandelenstroom +2.2% ·
netto nieuwe posities -14.3%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 92 | +8 | 58.13M | $2.24B | +14 | −5 |
| Q1 2026 | 86 | +8 | 53.00M | $1.32B | +12 | −4 |
| Q4 2025 | 78 | -2 | 55.44M | $1.41B | — | −2 |
| Q3 2025 | 16 | 0 | 40.91M | $659.48M | +1 | −2 |
| Q2 2025 | 14 | -2 | 41.55M | $664.87M | — | −2 |
| Q1 2025 | 13 | +2 | 9.17M | $156.74M | +2 | — |
| Q4 2024 | 11 | -2 | 8.24M | $204.11M | — | −2 |
| Q3 2024 | 12 | +1 | 7.03M | $200.30M | +1 | — |
| Q2 2024 | 11 | — | 7.29M | $192.47M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 18.60M | — | $297.59M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 18.60M | — | $297.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 18.60M | — | $297.59M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 18.60M | — | $297.59M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 18.60M | — | $297.59M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passief) | 7.03M | — | $112.42M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passief) | 7.03M | — | $112.42M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 7.03M | — | $112.42M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 7.03M | — | $112.42M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 7.03M | — | $112.42M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 5.85M | — | $93.57M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 3.34M | +316.0% | $53.38M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passief) | 2.83M | -8.3% | $45.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 1.83M | +9.2% | $29.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 1.83M | +9.2% | $29.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Norges Bank ✦ (passief) | 687.66K | +7.8% | $11.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 463.60K | +2086.8% | $7.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 350.39K | +6.9% | $5.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 241.40K | -39.0% | $3.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Millennium Management ✦ | 201.17K | +31.3% | $3.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 61.11K | -91.8% | $978,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 61.11K | -91.8% | $978,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | D. E. Shaw & Co. ✦ | 59.82K | +18.4% | $957,088 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | D. E. Shaw & Co. ✦ | 59.82K | +18.4% | $957,088 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 23.89K | -4.6% | $382,224 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 23.89K | -4.6% | $382,224 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 23.89K | -4.6% | $382,224 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Wellington Management ✦ | 23.89K | -4.6% | $382,224 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Viking Global Investors | $19.05M | was 0.1% |
| Marshall Wace | $2.37M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 215 houders, 110.50M aandelen, $2.64B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 3.06K aand · $134,953
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie